<code id='38F826D158'></code><style id='38F826D158'></style>
    • <acronym id='38F826D158'></acronym>
      <center id='38F826D158'><center id='38F826D158'><tfoot id='38F826D158'></tfoot></center><abbr id='38F826D158'><dir id='38F826D158'><tfoot id='38F826D158'></tfoot><noframes id='38F826D158'>

    • <optgroup id='38F826D158'><strike id='38F826D158'><sup id='38F826D158'></sup></strike><code id='38F826D158'></code></optgroup>
        1. <b id='38F826D158'><label id='38F826D158'><select id='38F826D158'><dt id='38F826D158'><span id='38F826D158'></span></dt></select></label></b><u id='38F826D158'></u>
          <i id='38F826D158'><strike id='38F826D158'><tt id='38F826D158'><pre id='38F826D158'></pre></tt></strike></i>

          hotspot

          hotspot

          author:leisure time    Page View:866
          Illustration: Alex Hogan/STAT; Photo: Courtesy Perrigo

          It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

          This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month. Their brief: Create a design that would stand out in America’s notoriously sprawling pharmacy aisles; inspire trust and confidence; be easy to remember and recognize; appeal to women — including teenagers — as well as trans men and nonbinary people; clearly communicate its purpose; be simple to carry and use; contain straightforward but accurate user information; and clear FDA requirements.

          advertisement

          Settling on the right approach took years of research and testing, which resulted in the name Opill and packaging featuring bright teal, saturated pink, and yellow, as well as a rounded font reminiscent of millennials’ ubiquitous favorite Gotham. All of these features are intended to set the product apart from the dozens of prescription contraceptive pills available in the U.S. market and internationally.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          FDA cancer chief on how to get things done: ‘Don’t tell anybody'
          FDA cancer chief on how to get things done: ‘Don’t tell anybody'

          AdobeWASHINGTON—TheFoodandDrugAdministration’stopcancerdrugregulatordoesn’talwaysaskforpermissionbef

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          A letter from the executive editor: STAT UnitedHealth investigation

          MikeReddyforSTATIwanttobringyourattentiontoavitallyimportant investigation STAThaspublishedtoday.For